• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

76
58
50
33
28

COUNTRY

14
13
12
11
7

CATEGORIES

  • 202
  • 88
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
8
203
211

PUBLISHED

121
121
122
211

PRODUCT TYPE

208
3

Search "Sandoz Generics Company Intelligence Report" returned 211 results.

Sandoz International GmbH - Strategy and SWOT Report

Sandoz International GmbH - SWOT Analysis company profile is the essential source for top-level company data and information. Sandoz International GmbH - SWOT Analysis examines the company’s key business...

June 2014
FROM

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence...

December 2012
FROM

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent...

May 2012
FROM

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent...

May 2012
FROM

The Pharmaceutical Market: Germany

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting...

May 2012
FROM

Global Pharmaceutical Logistics 2012

Global pharma supply chains are undergoing a transformation Structural changes in the pharmaceutical manufacturing industry are set to create significant opportunities for logistics service providers...

December 2011
FROM

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

February 2015
FROM

Escitalopram - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

August 2015

Escitalopram - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

August 2015

Competitor Analysis: Human Growth Hormone (hGH)

The Competitive Intelligence Report Human Growth Hormone (hGH) as of April 2013 provides a competitor analysis in the development pipeline of biosimilar versions of somatropin and next generation biobetter/biosuperior...

April 2013
FROM

The Pharmaceutical Market: USA

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting...

May 2012
FROM

The Pharmaceutical Market: Brazil

This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens...

May 2012
FROM

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

July 2012
FROM

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Anemia-API Insights

Summary Anemia-API Insights, 2015 report provides Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United...

August 2015
FROM

Competitor Analysis: G-CSF and GM-CSF

he present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets...

April 2013
FROM

Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

August 2015
FROM

Pneumonia-API Insights

Summary Pneumonia-API Insights, 2015 report provides Pneumonia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the...

August 2015
FROM

Septicaemia-API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

August 2015
FROM

Bronchitis-API Insights

Summary Bronchitis-API Insights, 2015 report provides Bronchitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on...

August 2015
FROM
Loading Indicator

Our Clients

Abbott Laboratories Ltd. Ford Motor Company Honeywell International, Inc. Nike, Inc. Deloitte LLP. IMAX Corporation